Paul Yager receives funding to develop low-cost at-home testing to monitor chronic diseases
Paul Yager has been awarded a Washington Research Foundation Phase 1 commercialization grant to support his groundbreaking work in paper-based microfluidics.
Paul Yager has been awarded a Washington Research Foundation Phase 1 commercialization grant to support his groundbreaking work in paper-based microfluidics.
A number of UW Bioengineering faculty members quickly pivoted and are adapting their research to addressing the needs created by the coronavirus pandemic. From developing rapid at-home tests and protective masks to vaccines and treatments, here is a sampling of some of the ways UW BioE faculty, staff and students are stepping up to help.
The Paul Yager Lab at UW Bioengineering is applying its rapid, low-cost testing technology, called UbiNAAT, to COVID-19 tests, which could be used by untrained people in their homes as well as in health care facilities and low-resource settings around the world.
UW Bioengineering master's student Dylan Guelig is developing a cartridge-style two-dimensional paper network test that can detect minute amounts of proteins present in deadly flu viruses as well as a similar test for the Ebola virus.
Professor Paul Yager, noted disease diagnostics innovator and former department chair, has been elected to the National Academy of Inventors. NAI Fellows demonstrate a prolific spirit of innovation in creating or facilitating outstanding inventions that have made a tangible impact on quality of life, economic development and societal welfare.
The 2017-2018 academic year marks the 50th anniversary of the founding of UW’s Center for Bioengineering and the 20th anniversary of the creation of the UW Department of Bioengineering, a department jointly operated by the UW School of Medicine and College of Engineering.
The 2016 UW Bioengineering Summer Camp in Global Health concluded on Friday, July 22. The [...]
Paul Yager and other researchers are developingfast, inexpensive, highly sensitive and simple disease testing technology that anyone can use, anywhere, without needing access to power, running water or special equipment. The devices could lead to faster treatment, limit spread of infectious disease, save hundreds of thousands of lives and reduce the cost of health care.